Ideas Lab: Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications | 24 552

Opportunity Information: Apply for 24 552

The National Science Foundation (NSF), through its Directorate for Technology, Innovation and Partnerships (TIP), is soliciting proposals under an Ideas Lab opportunity called CFIRE (Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications). The program is built around accelerating use-inspired and translational research and development that strengthens U.S. competitiveness and expands the U.S. bioeconomy. CFIRE centers on cell-free, in-vitro biochemical manufacturing platforms that can perform core biological processes such as DNA transcription and translation outside living cells, offering an alternative to traditional cell-based, in-vivo bioreactors. The opportunity frames cell-free systems as a fast-growing but still early-stage technology area with clear advantages and clear barriers that must be overcome for broader adoption.

The core motivation is that cell-free systems can, in principle, deliver rapid turnaround and more flexible, distributed manufacturing because they are not constrained by keeping cells alive and growing. They can also allow tighter instrumentation, monitoring, and control of reaction conditions, and may simplify downstream processing by avoiding complications introduced by cell biomass and cell membranes during purification. Another highlighted advantage is that cell-free platforms can enable production of compounds that are difficult or impractical to make in living cultures, including products that are toxic to cells or products (such as certain hydrocarbons) that cells may metabolize or consume, reducing yield. Despite these benefits, the solicitation emphasizes that current cell-free manufacturing remains significantly more expensive than cell-based approaches and is limited to a narrower set of practical applications, which restricts adoption and slows learning-by-doing improvements.

CFIRE sets three primary technical and translational goals: (1) reduce the cost of cell-free systems, (2) expand the range and capabilities of what cell-free systems can do, and (3) develop and demonstrate cost-effective, use-inspired applications. A key theme is creating a reinforcing improvement cycle: lowering cost should increase real-world adoption; higher adoption should attract more investment, generate better operational knowledge, and produce more data; and that, in turn, should further reduce cost and improve performance. To keep projects grounded and adoption-oriented, NSF indicates that funded efforts should focus on one or more specific, well-defined use cases rather than remaining purely general or exploratory.

The opportunity also spells out the types of breakthroughs it wants to see. First, it seeks compelling demonstrations that prove feasibility and show concrete advantages of cell-free approaches, with a specific emphasis on applications beyond human therapeutics. In other words, while medical applications may be relevant, the program particularly wants to push cell-free technology into broader industrial, environmental, agricultural, defense, energy, materials, or other non-therapeutic domains where cell-free systems could offer unique value. Second, CFIRE encourages creation of shared infrastructure that third parties can readily access and reuse, such as standardized tools, protocols, kits, datasets, and characterization or measurement services. The intent is to reduce duplication, make performance easier to compare across labs and organizations, and accelerate diffusion of best practices. Third, CFIRE explicitly includes workforce development, aiming to train translationally oriented talent who can connect fundamental advances to practical, use-driven deployments of cell-free technology.

A defining feature of this funding opportunity is that it uses NSF's Ideas Lab process. Instead of operating like a conventional proposal call only, it begins with an intensive workshop-style meeting that brings together participants with diverse perspectives. The Ideas Lab is intended to sharpen the problem framing and catalyze new, cross-disciplinary teams and concepts. The workshop objectives include identifying promising routes to major cost reductions, establishing acceptable standards for fidelity and reproducibility (so results can be trusted and replicated), expanding the technical capability envelope to enable broader adoption, and prioritizing specific use-driven applications beyond human therapeutics that can serve as clear demonstration targets.

Eligibility is broad across the U.S. research and innovation ecosystem. Eligible applicants include U.S. institutions of higher education (two- and four-year institutions, including community colleges), U.S.-based for-profit organizations (including small businesses) with strong research or educational capabilities and a strong innovation orientation, and U.S. non-profit, non-academic organizations such as independent research laboratories, professional societies, museums, and observatories tied to research or education. Tribal Nations that are federally recognized are eligible. Other Federal Agencies and Federally Funded Research and Development Centers (FFRDCs) may apply but are instructed to contact the relevant program before preparing a submission. Foreign organizations may also be involved; however, for cooperative projects with U.S. and foreign participants, NSF funding is limited to the U.S. portion. If a proposal routes funding to an international branch campus of a U.S. institution (including via subawards or consultants), the proposer must explain why that overseas performance is beneficial and why the work cannot be performed at the U.S. campus.

Key funding details in the notice include an award ceiling of $3,750,000, an expectation of approximately 8 awards, and an original closing date of 2024-09-20. The opportunity is listed as a discretionary grant in the science and technology research and development category, under NSF (CFDA number 47.084), and identified by Funding Opportunity Number 24-552. Overall, CFIRE is positioned as a targeted push to move cell-free manufacturing from promising niche capability to more affordable, standardized, and broadly usable technology, with real-world demonstrations, reusable community infrastructure, and a workforce pipeline designed to sustain translation and adoption.

• The National Science Foundation in the science and technology and other research and development sector is offering a public funding opportunity titled "Ideas Lab: Advancing Cell-Free Systems Toward Increased Range of Use-Inspired Applications" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 47.084.
• This funding opportunity was created on 2024-03-02.
• Applicants must submit their applications by 2024-09-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $3,750,000.00 in funding.
• The number of recipients for this funding is limited to 8 candidate(s).
• Eligible applicants include: Others.

Apply for 24 552

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: